Capecitabine

Oncologist

Volumn 12, Issue 2, 2007, Pages 152-155

  Schellens, Jan H M ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; COUMARIN; DOCETAXEL; EMOLLIENT AGENT; HEPARIN; LOPERAMIDE; PHENYTOIN; PYRIDOXINE; SORIVUDINE; THYMIDYLATE SYNTHASE;

ADVANCED CANCER; BONE MARROW TOXICITY; BREAST CANCER; COLON CANCER; COLORECTAL CANCER; CREATININE CLEARANCE; DIARRHEA; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG INDICATION; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG STORAGE; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FATIGUE; HAND FOOT SYNDROME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MASS SPECTROMETRY; MONOTHERAPY; MUCOSA INFLAMMATION; NAUSEA; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN BINDING; RECOMMENDED DRUG DOSE; REVIEW; THORAX PAIN; TREATMENT DURATION;

ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL TRIALS; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; NEOPLASMS; PRODRUGS;

EID: 33847066736     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-2-152     Document Type: Review

References (7)

1. Milano G, Schellens JHM. Pyrimidine antimetabolites. In: Schellens JHM, McLeod HL, Newell DR eds. Cancer Clinical Pharmacology. Oxford: University Press, 2005:51-62.
2. Xu Y, Grem JL. Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma. J Chromatogr B Biomed Appl 2003; 783:273-285.
3. Twelves C, Glynne-Jones R, Cassidy J et al. Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. Clin Cancer Res 1998;4:941-948.
4. Beijnen JH, Schellens JHM. Drug interactions in oncology. Lancet Oncology 2004; 5:689-696.
5. Giescke R, Burger HU, Reigner B et al. Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients. Br J Clin Pharmacol 2003;55:252-263.
6. Raida M, Schwabe W, Hausler P, et al. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5′-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls. Clin Cancer Res 2001;7:2832-2839.
7. Kuppens IE, Boot H, Beijnen JH et al. Capecitabine induces severe angina-like chest pain. Ann Intern Med 2004;140:494-495.